Sanofi launches Enterogermina, a new treatment for gastrointestinal disorders

Microbiota are microbes that live on the surface of skin, in saliva, eyes and the gastrointestinal tract. The microbiota found in the stomach is to control a person's weight and protect against infection.

"Although we are born with these microorganisms in our bodies, poor dietary habits can disrupt the levels of microbiota in the system and cause more damage than harm," said Dr, Antonio Gasbarrini, M.D from the Internal Medicine Department at Catholic University, Gemelli Hospital, Italy, who presented on the importance of using probiotics in the efforts to maintain a healthy number of bacteria. "Probiotics and postbiotics are part of biotherapy, a new direction in medicine when treating infections and gastric conditions."

Conditions like diabetes, obesity or an inappropriate use of medications such as antibiotics can be linked to adiposity, which occurs when person weight is no longer controlled by these microbes. It is when probiotics can be prescribes to return the balance within the gastrointestinal tract.

"Bacillus clausii is part of a new class of probiotics that help stimulates the immune system to protect the gastrointestinal tract against infection or other gastrointestinal diseases," said Dr. Mohamad Miqdady, M.D., Head of Pediatric Gastroenterology at Sheikh Khalifa Medical City in Abu Dhabi, "Due to the increasing number of diabetes and obesity cases in the UAE, gastrointestinal diseases cases are also on the rise. Probiotics such as Enterogermina, are prescribed as part of the treatment to manage the microbiota in the system."

Enterogermina is now available in the UAE at pharmacies. Speak to a doctor before taking any medications.